Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
NACLC 2019
2019 North American Conference on Lung Cancer
(Chicago, IL, USA): October 10 – 12, 2019
The NACLC 2019 Virtual Meeting will be composed of the PowerPoint slides of the presentations only.Presentation Date(s):- October 10 – 12, 2019
- Total Presentations: 125
-
+
OA02 - Screening and IO Toxicity
- Type: Oral Abstract Session
- Track:
- Presentations: 10
- Slides Available
- Coordinates: 10/12/2019, 09:45 - 11:15, Imperial Ballroom (B2 Level)
-
+
OA02.01 - Outcomes of Integrating Individualized Tobacco Cessation Counseling in a Lung Cancer Screening Program (Slides Available)
09:45 - 09:52 | Author(s): Matthew Steliga
- Abstract
Loading... -
+
OA02.02 - Outcomes of Smoking Cessation Counseling in a Surgical Clinic. (Slides Available)
09:52 - 09:59 | Author(s): Matthew Steliga
- Abstract
Loading... -
+
OA02.03 - CNS Metastasis as Exclusion Criteria in Clinical Trials Involving Extensive-Stage Small Cell Lung Cancer (Slides Available)
10:59 - 11:06 | Author(s): Andy Wang
- Abstract
Loading... -
+
OA02.04 - Discussant: Smoking Cessation and Inclusivity in Clinical Trials (Slides Available)
10:06 - 10:16 | Author(s): Ticiana Leal
- Abstract
No abstract available for this presentation
-
+
OA02.05 - Clinical-radiomic Models Predict Overall Survival Among Non-small Cell Lung Cancer Patients Treated with Immunotherapy (Slides Available)
11:16 - 11:26 | Presenter: Ilke Tunali
- Abstract
Loading... -
+
OA02.06 - Lung Cancer Screening in Patients With Versus Without a Personal History of Cancer
11:26 - 11:33 | Presenter: M. Patricia Rivera
- Abstract
Loading... -
+
OA02.07 - Low Dose CT Lung Screening in First Responders (Slides Available)
10:33 - 10:40 | Presenter: Vershalee Shukla
- Abstract
Loading... -
+
OA02.08 - Peritumoral and Intratumoral Radiomic Features Identify Aggressive Screen-detected Early-stage Lung Cancers (Slides Available)
10:40 - 10:47 | Presenter: Jaileene Perez Morales
- Abstract
Loading... -
+
OA02.09 - Multi-Planar Lung Cancer Measurements Provide Improved Accuracy in Clinical Staging (Slides Available)
11:47 - 11:54 | Presenter: Erin M. Corsini
- Abstract
Loading... -
+
OA02.10 - Discussant: Radiomics, Screening and Imaging (Slides Available)
10:54 - 11:04 | Author(s): Sharyn Katz
- Abstract
No abstract available for this presentation
-
+
OA03 - IO Concerns and Targeted Therapies
- Type: Oral Abstract Session
- Track:
- Presentations: 10
- Slides Available
- Coordinates: 10/12/2019, 09:45 - 11:15, Rouge (Lobby Level)
-
+
OA03.01 - Biomarkers of Autoimmune Toxicity in Metastatic SCLC Patients Receiving PD-1/PDL-1 Targeted Therapy (Slides Available)
09:45 - 09:52 | Author(s): Imad Tarhoni
- Abstract
Loading... -
+
OA03.02 - Outcomes of Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC) with Brain Metastases Treated with Pembrolizumab (Slides Available)
09:52 - 09:59 | Presenter: Lova Sun
- Abstract
Loading... -
+
OA03.03 - Multi-institutional Study of Pneumonitis after Treatment with Durvalumab and Chemoradiotherapy for Non-Small Cell Lung Cancer (Slides Available)
09:59 - 10:06 | Presenter: Timothy Sita
- Abstract
Loading... -
+
OA03.04 - Analysis of Patient Microbiome and Its Correlation to Immunotherapy Response and Toxicity in Lung Cancer. (Slides Available)
10:06 - 10:13 | Author(s): Justin Chau
- Abstract
Loading... -
+
OA03.05 - Discussant: Predictors of IO Toxicity (Slides Available)
10:13 - 10:23 | Author(s): Kristen Marrone
- Abstract
No abstract available for this presentation
-
+
OA03.06 - Impact of an EGFR-lung Cancer Diagnosis on Quality of Life of Patients: Learnings from Project PRIORITY (Slides Available)
10:23 - 10:30 | Author(s): Upal Basu Roy
- Abstract
Loading... -
+
OA03.07 - Evaluating Racial Differences in KRAS-Mutant Non-Small Cell Lung Cancer (Slides Available)
10:30 - 10:37 | Presenter: Jacqueline Aredo
- Abstract
Loading... -
+
OA03.08 - Clinical Utility of ctDNA Driver Genomic Alterations (GA) Directing Targeted Therapy in Untreated Advanced NSCLC Patients (Slides Available)
10:37 - 10:44 | Author(s): Laura Mezquita
- Abstract
Loading... -
+
OA03.09 - Overall Survival in Patients with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: An Update of the GioTag Study (Slides Available)
10:44 - 10:51 | Author(s): Maximilian J. Hochmair
- Abstract
Loading... -
+
OA03.10 - Discussant: Targeted Therapies: Partnerships, Inequities, and Best Therapies (Slides Available)
10:51 - 11:01 | Author(s): Christine Lovly
- Abstract
No abstract available for this presentation
-
+
GS08 - Closing Plenary
- Type: Invited Speaker Session
- Track:
- Presentations: 4
- Slides Available
- Coordinates: 10/12/2019, 11:30 - 12:30, Imperial Ballroom (B2 Level)
-
+
GS08.01 - Novel Tumor Biomarkers and Tumor Immune Profiling (Slides Available)
11:30 - 11:45 | Presenter: Kurt Schalper
- Abstract
No abstract available for this presentation
-
+
GS08.02 - Microbiome and Implications for Response to IO
11:45 - 12:00 | Presenter: Thomas Gajewski
- Abstract
No abstract available for this presentation
-
+
GS08.03 - Treatment of Oligometastaic Disease Denovo and at Progression with Driver Mutations, on IO or Neither (Slides Available)
12:00 - 12:15 | Author(s): Puneeth Iyengar
- Abstract
No abstract available for this presentation
-
+
GS08.04 - Closing Remarks
12:15 - 12:30 | Author(s): Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
GS09 - Women in Thoracic Oncology Networking Lunch
- Type: Invited Speaker Session
- Track:
- Presentations: 2
- Coordinates: 10/12/2019, 12:30 - 13:30, Rouge (Lobby Level)
-
+
GS09.01 - An Unscripted Life: Using Improvisational Theater Techniques to Help Women in Medicine Claim Power, Collaborate and Communicate
12:30 - 13:10 | Presenter: Katie Watson
- Abstract
No abstract available for this presentation
-
+
GS09.02 - Q&A
13:10 - 13:30
- Abstract
No abstract available for this presentation